TELA Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: TELA Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q3 2024.
TELA Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.08M, a 21% decline year-over-year.
TELA Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.51M, a 6.54% decline year-over-year.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.03M, a 26.1% increase from 2022.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.99M, a 8.96% increase from 2021.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.66M, a 77.9% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$4.51M	$1.08M	-$288K	-21%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$4.8M	$1.09M	-$204K	-15.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$5.01M	$1.1M	-$26K	-2.31%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$5.03M	$1.24M	+$202K	+19.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-22
Q3 2023	$4.83M	$1.37M	+$342K	+33.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-08
Q2 2023	$4.49M	$1.29M	+$272K	+26.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	$4.22M	$1.13M	+$227K	+25.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$3.99M	$1.04M	+$217K	+26.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-22
Q3 2022	$3.77M	$1.03M	+$294K	+40.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$3.48M	$1.02M	-$390K	-27.6%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$3.87M	$901K	+$207K	+29.8%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$3.66M	$822K	+$250K	+43.7%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-22
Q3 2021	$3.41M	$733K	+$190K	+35%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$3.22M	$1.41M	+$918K	+186%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$2.3M	$694K	+$245K	+54.6%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$2.06M	$572K	+$298K	+109%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-23
Q3 2020	$1.76M	$543K	+$479K	+748%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	$1.28M	$494K	+$435K	+737%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$846K	$449K	+$389K	+648%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	$457K	$274K			Oct 1, 2019	Dec 31, 2019	10-K	2022-03-23
Q3 2019		$64K	+$3K	+4.92%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019		$59K			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019		$60K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15
Q3 2018		$61K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-12-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.